Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells
Open Access
- 1 February 2000
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 59 (2) , 146-148
- https://doi.org/10.1136/ard.59.2.146
Abstract
BACKGROUND The multidrug resistance phenomenon results from the expression of P-glycoprotein (P-gp), a drug-efflux pump. Corticosteroids are substrates for P-gp, whose function can be inhibited by cyclosporin. This study evaluates the ability of cyclosporin to modulate dexamethasone uptake in multidrug resistant cells. METHODS The K 562 cell line, which does not express P-gp and a P-gp expressing clone, K562/ADM, were used. Cells were incubated with H3-dexamethasone in the absence or presence of cyclosporin at various concentrations. Then, cells were washed, lysed, and radioactivity was measured. RESULTS The uptake of dexamethasone alone was higher in sensitive than in resistant cells. Addition of cyclosporin induced a dose dependent increase of dexamethasone uptake in resistant cells, whereas the drug did not influence dexamethasone uptake in parental cells. CONCLUSION Cyclosporin, at therapeutic concentrations induces a moderate, but significant increase in dexamethasone accumulation in multidrug resistant cells. Thus, cyclosporin might increase the intestinal absorption of corticosteroids or their accumulation in mononuclear cells, or both, thereby increasing their therapeutic efficacy.Keywords
This publication has 11 references indexed in Scilit:
- Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligandsThe Journal of Steroid Biochemistry and Molecular Biology, 1998
- Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressantsMolecular and Cellular Endocrinology, 1998
- Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1997
- Expression of a multidrug resistance gene in human rheumatoid synoviumRheumatology International, 1995
- Modulators of Multidrug Resistance: Preclinical StudiesHematology/Oncology Clinics of North America, 1995
- Cortisol is transported by the multidrug resistance gene product P-glycoproteinBritish Journal of Cancer, 1993
- The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosaGastroenterology, 1992
- Multidrug resistance (mdr) genes in human cancerBritish Journal of Cancer, 1991
- P-glycoproteins in pathology: The multidrug resistance gene family in humansHuman Pathology, 1990
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989